A clinical trial to study the effects of two different doses of dexamethasone in combination with levobupivacaine for ultrasound guided block in patients undergoing surgery for fracture of thigh bone

Comparison of 4 mg versus 8 mg of Dexamethasone as an adjuvant to Levobupivacaine in ultrasound-guided fascia iliaca block for proximal femoral nail surgery under spinal anaesthesia: A randomized double-blind trial. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054066

Enrollment

100

Registered

2023-06-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 4 mg dexamethasone: 4 mg (1ml) dexamethasone and 1 ml normal saline combined with 28 ml of 0.25% levobupivacaine for ultrasound guided fascia iliaca block before spinal anaesthesia Cont

Eligibility

Inclusion criteria

Inclusion criteria: 1. A.S.A. physical status I and II 2. patients undergoing Proximal femoral nailing surgery

Exclusion criteria

Exclusion criteria: 1. Patients with coagulopathies and bleeding diathesis. 2. Patients with known hypersensitivity to study drugs. 3. Patients with infection at the site of needle injection. 4. Patients with a previous history of inguinal hernia surgery and femoral bypass graft.

Design outcomes

Primary

Measure	Time frame
to compare the postoperative pain using visual analogue scale between the two groups to compare the duration of analgesia between the two groupsTimepoint: on arrival to post anaesthesia care unit 2hours 4 hours 6 hours 12 hours & 24 hours postoperatively	—

Secondary

Measure	Time frame
To compare the need for rescue analgesia & total analgesic requirement in both To compare the adverse effects in both groups groupsTimepoint: 24 hours	—

Countries

India

Contacts

Public ContactDR MAHENDRAKAR SREEVANI

Government Medical College Kadapa

visalajayam@gmail.com9440259160

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026